Recombinant monoclonal antibody to CCR2. Plozalizumab is a humanized monoclonal antibody that can be potentially used in the treatment of Atherosclerosis, Diabetic nephropathies, Malignant melanoma. It binds to CCR2 and prevents binding of the endothelium-derived CLL2 (monocyte chemoattractant protein-1 or MCP1) to its receptor CCR2.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Afuco™ Anti-CCR2 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-444CQ)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CCR2. It is a humanized monoclonal antibody that can be potentially used in the treatment of Atherosclerosis, Diabetic nephropathies, Malignant melanoma. It binds to CCR2 and prevents binding of the endothelium-derived CLL2 (monocyte chemoattractant protein-1 or MCP1) to its receptor CCR2.
DrugMonitor™ Anti-Plozalizumab Antibody (VS-1224-YC931)Plozalizumab has been researched for treating atherosclerosis as a humanized monoclonal antibody specifically targeting CCR2. The DrugMonitor™ Anti-Plozalizumab Antibody (VS-1224-YC931) is an anti-drug antibody (ADA) against Plozalizumab. This drug-based antibody is raised in mice immunized with the Plozalizumab. The anti-Plozalizumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Plozalizumab in samples.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-159-F(E) | Recombinant Anti-human CCR2 Antibody Fab Fragment | FC, ELISA, FuncS | Fab |
MHH-159-F(E) | Recombinant Human Anti-human CCR2 Antibody Fab Fragment | FC, WB, FuncS | Fab |
HPAB-0247-YC-F(E) | Human Anti-CCR2 Recombinant Antibody; Fab Fragment (HPAB-0247-YC-F(E)) | ELISA, FC | Human Fab |
HPAB-0248-YC-F(E) | Human Anti-CCR2 Recombinant Antibody; Fab Fragment (HPAB-0248-YC-F(E)) | ELISA, FC | Human Fab |
HPAB-1571WJ-F(E) | Human Anti-CCR2 Recombinant Antibody; Fab Fragment (clone hu1D9) | ELISA, WB | Human Fab |
There are currently no Customer reviews or questions for TAB-444CQ. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.